Free Trial

MiMedx Group (MDXG) Earnings Date, Estimates & Call Transcripts

MiMedx Group logo
$7.90 -0.20 (-2.47%)
Closing price 04:00 PM Eastern
Extended Trading
$8.05 +0.15 (+1.90%)
As of 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MiMedx Group Latest Earnings Summary

Upcoming Q1
Earnings Date
Apr. 29After Market ClosesEstimated
Actual EPS
(Feb. 26)
$0.07
Consensus EPS
(Feb. 26)
$0.07

MiMedx Group announced Q4 2024 earnings on February 26, 2025, reporting an EPS of $0.07, which met analysts' consensus estimates of $0.07. Quarterly revenue was reported to be $92.91 million, above analyst estimates of $89.42 million. With a trailing EPS of $0.28 and a P/E Ratio of 14.36, MiMedx Group's earnings are expected to grow 6.67% next year, from $0.30 to $0.32 per share.

MDXG Upcoming Earnings

MiMedx Group's next earnings date is estimated for Tuesday, April 29, 2025, based off prior year's reporting schedules.

Get MiMedx Group Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MiMedx Group and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MDXG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MDXG Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

MiMedx Group Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20251$0.06$0.06$0.06 
Q2 20251$0.07$0.07$0.07 
Q3 20251$0.07$0.07$0.07 
Q4 20251$0.08$0.08$0.08 
FY 20254$0.28$0.28 $0.28
Remove Ads

MiMedx Group Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/29/2025
(Estimated)
-------
2/26/2025Q4 2024$0.07$0.07-$0.05$89.42M$92.91M
10/30/2024Q3 2024$0.05$0.07+$0.02$0.09$81.00M$84.06M
7/31/2024Q2 2024$0.08$0.08-$0.04$88.44M$87.21M
4/30/2024Q1 2024$0.04$0.07+$0.03$0.08$79.36M$84.71M
2/28/2024Q4 2023$0.08$0.04 -$0.04-$0.24$85.58M$86.83M
10/30/2023Q3 2023$0.04$0.05+$0.01$0.04$76.69M$81.71M
5/2/2023Q1 2023-$0.09-$0.06+$0.03-$0.06$63.48M$71.68M

MiMedx Group Earnings - Frequently Asked Questions

MiMedx Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 29th, 2025 based off last year's report dates. Learn more on MDXG's earnings history.

In the previous quarter, MiMedx Group (NASDAQ:MDXG) reported $0.07 earnings per share (EPS) to hit the analysts' consensus estimate of $0.07. Learn more on analysts' earnings estimate vs. MDXG's actual earnings.

The conference call for MiMedx Group's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for MiMedx Group's latest earnings report can be read online.
Read Transcript

MiMedx Group (NASDAQ:MDXG) has a recorded annual revenue of $348.88 million.

MiMedx Group (NASDAQ:MDXG) has a recorded net income of $58.23 million. MDXG has generated $0.28 earnings per share over the last four quarters.

MiMedx Group (NASDAQ:MDXG) has a trailing price-to-earnings ratio of 14.29 and a forward price-to-earnings ratio of 26.22.

MiMedx Group's earnings are expected to grow from $0.30 per share to $0.32 per share in the next year, which is a 6.67% increase.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:MDXG) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners